BBP
BBP
About Virtus Biotech ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
About Virtus Biotech ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 IBRX | ImmunityBio, Inc. | 5.20% | 529.30K | $4.09M |
 IOVA | Iovance Biotherapeutics, Inc. | 3.11% | 567.79K | $2.44M |
 MRNA | Moderna, Inc. | 2.57% | 42.40K | $2.02M |
 KALV | KalVista Pharmaceuticals, Inc. | 2.52% | 73.87K | $1.98M |
 NVAX | Novavax, Inc. | 2.50% | 190.13K | $1.96M |
 AXSM | Axsome Therapeutics, Inc. | 2.50% | 8.43K | $1.96M |
 MIRM | Mirum Pharmaceuticals, Inc. | 2.44% | 19.22K | $1.91M |
 TVTX | Travere Therapeutics, Inc. | 2.18% | 35.86K | $1.71M |
 ROIV | Roivant Sciences Ltd. | 2.15% | 56.52K | $1.69M |
 KRYS | Krystal Biotech, Inc. | 2.02% | 5.11K | $1.58M |
 LEGN | Legend Biotech Corporation | 2.01% | 55.97K | $1.58M |
 EXEL | Exelixis, Inc. | 2.00% | 30.56K | $1.57M |
 LGND | Ligand Pharmaceuticals Incorporated | 1.97% | 6.59K | $1.55M |
 TGTX | TG Therapeutics, Inc. | 1.97% | 39.84K | $1.55M |
 KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.94% | 30.03K | $1.53M |
 BCRX | BioCryst Pharmaceuticals, Inc. | 1.91% | 165.01K | $1.50M |
 UTHR | United Therapeutics Corporation | 1.81% | 2.53K | $1.42M |
 GILD | Gilead Sciences, Inc. | 1.80% | 10.38K | $1.41M |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 1.79% | 17.82K | $1.41M |
 BIIB | Biogen Inc. | 1.79% | 7.17K | $1.41M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Bermuda
Denmark
China
Canada
Germany
Cayman Islands
SwitzerlandSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Bermuda Denmark China Canada Germany Cayman Islands SwitzerlandHoldings (Top 20)
IBRX
ImmunityBio, Inc.
IOVA
Iovance Biotherapeutics, Inc.
MRNA
Moderna, Inc.
KALV
KalVista Pharmaceuticals, Inc.
NVAX
Novavax, Inc.
AXSM
Axsome Therapeutics, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
TVTX
Travere Therapeutics, Inc.
ROIV
Roivant Sciences Ltd.
KRYS
Krystal Biotech, Inc.
LEGN
Legend Biotech Corporation
EXEL
Exelixis, Inc.
LGND
Ligand Pharmaceuticals Incorporated
TGTX
TG Therapeutics, Inc.
KNSA
Kiniksa Pharmaceuticals, Ltd.
BCRX
BioCryst Pharmaceuticals, Inc.
UTHR
United Therapeutics Corporation
GILD
Gilead Sciences, Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
BIIB
Biogen Inc.